Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Prevalence of retinal defect in a population with infantile spasms attributed to tuberous sclerosis: pre drug(baseline) vs. drug exposure (6,12 months exposure)

FY 2010-11

Summary
Infantile spasms(IS) is a type of epilepsy characterized by distinctive seizure patterns with onset usually occurring during the first year of life. Vigabatrin (VGB) is an antieplileptic drug that is sometimes used to treat children with Infantile Spasms and works by decreasing the concentration of the neurotransmitter GABA in the brain and retina. VGB has been found to be highly effective in treating IS and among patients with Tuberous Sclerosis (TS), it has been found to be more efficacious than with patients with other aetiologies. However, VGB causes toxicity in the form of a visual field defect in approximately 30% of the adult population. In infants, a sustained reduction in the electroretinogram (ERG) 30-Hz flicker amplitude is considered a surrogate marker of visual field defect. This project will be a retrospective case study and a prospective cohort study which examines differences in the prevalence and patterns of toxicity in infants who have been diagnosed with TS and in infants who have been diagnosed with other aetiologies (Non-TS) of IS. Statistical analysis and regression analysis of data will be performed to determine differences in ERG results of the two populations.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
225390
Name
Kumarappah Ananthavalli
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Prevalence of retinal defect in a population with infantile spasms attributed to tuberous sclerosis: pre drug(baseline) vs. drug exposure (6,12 months exposure)
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Acth; Drug Therapy; Electrophysiology; Infantile Spasms; Peripheral Visual Field Defects; Retinal Toxicity; Tuberous Sclerosis; Vigabatrin; West Syndrome
Abstract
Infantile spasms(IS) is a type of epilepsy characterized by distinctive seizure patterns with onset usually occurring during the first year of life. Vigabatrin (VGB) is an antieplileptic drug that is sometimes used to treat children with Infantile Spasms and works by decreasing the concentration of the neurotransmitter GABA in the brain and retina. VGB has been found to be highly effective in treating IS and among patients with Tuberous Sclerosis (TS), it has been found to be more efficacious than with patients with other aetiologies. However, VGB causes toxicity in the form of a visual field defect in approximately 30% of the adult population. In infants, a sustained reduction in the electroretinogram (ERG) 30-Hz flicker amplitude is considered a surrogate marker of visual field defect. This project will be a retrospective case study and a prospective cohort study which examines differences in the prevalence and patterns of toxicity in infants who have been diagnosed with TS and in infants who have been diagnosed with other aetiologies (Non-TS) of IS. Statistical analysis and regression analysis of data will be performed to determine differences in ERG results of the two populations.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kumarappah, Ananthavalli
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~